A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal

Kathrine S Øye1, Geeta Gulati, Bjørn A Graff

  • 1Group of Radiation Biology and Tumor Physiology, Department of Radiation Biology, Institute for Cancer Research,The Norwegian Radium Hospital, Montebello, Oslo, Norway.

Microvascular Research
|August 11, 2007
PubMed

Insights

This study introduces a new imaging technique to analyze blood flow in tumors and normal tissues. The method accurately maps blood flow velocity and supply time across entire tumor vascular networks.

Area of Science:

  • Physiology
  • Biomedical Engineering
  • Oncology

Background:

  • Understanding tumor vascular dynamics is crucial for developing effective cancer therapies.
  • Current methods for assessing tumor blood flow can be limited in resolution and scope.

Purpose of the Study:

  • To develop and validate a novel first-pass imaging method for studying microvascular blood flow.
  • To enable simultaneous mapping of blood flow velocity and blood supply time (BST) in entire tumor vascular networks.

Main Methods:

  • Intravenous administration of a bolus dose of a fluorescence-labeled macromolecule.
  • Detection of the fluorescence signal as the bolus traverses the vascular network in mouse dorsal window chamber preparations.
  • High-sensitivity imaging allowing detection in individual microvessels of tumors and normal tissues.

Main Results:

  • The method successfully measured blood flow velocity and direction in individual microvessels of normal and malignant tissues.
  • Accurate determination of blood supply time (BST) for individual tumor vessel segments was achieved.
  • Comprehensive maps of blood flow velocity and BST across the entire microvascular network of xenografted tumors were generated.

Conclusions:

  • This novel imaging method provides a sensitive and comprehensive approach to study tumor vascular physiology.
  • The technique allows for detailed analysis of blood flow dynamics, crucial for preclinical cancer research and therapeutic development.

Related Concept Videos